Ritholtz Wealth Management Scynexis Inc Transaction History

Ritholtz Wealth Management

  • $3.28 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$1.4 - $2.77 $15,497 - $30,663
11,070 New
11,070 $22,000
Q4 2023

Jan 18, 2024
SELL
$1.56 - $2.24 $859 - $1,234
-551 Reduced 3.02%
17,696 $39,000
Q3 2023

Oct 13, 2023
BUY
$1.93 - $3.64 $35,216 - $66,419
18,247 New
18,247 $41,000

Others Institutions Holding SCYX

# of Institutions
48
Shares Held
13.7M
Call Options Held
21.9K
Put Options Held
2.6K
View Full List

About SCYNEXIS INC

SCYX Quotes by TradingView
  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $33M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Ritholtz Wealth Management Portfolio

Follow Ritholtz Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email